Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects


Researchers investigated the efficacy of a booster dose of the bivalent mRNA COVID-19 vaccine in preventing severe outcomes during SARS-CoV-2 infections.

Inflammation levels tied to severity of blood cancer

Previous article

Review shows metformin usage to be associated with better COVID-19 outcomes

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News